Cell cycle transitions in eukaryotes are driven by cyclin-dependent kinases (for example, Cdk1 and Cdk2), which are regulated by the availability of their cyclin partners (for example, CycA and ...
12d
MyChesCo on MSNNiKang Advances CDK2 Degrader with Key Milestone in Cancer Treatment TrialWILMINGTON, DE — NiKang Therapeutics® Inc. has achieved a pivotal step in the development of its first-in-class CDK2 degrader ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results